跳至主要内容
临床试验/NCT07702916
NCT07702916Enrolling By Invitation不适用

Disentangling the Effects of Infrastructure, Sensitization, and Sanitary Pad Distribution on Health, Learning, and Psychosocial Wellbeing Among Adolescent Girls in Rural Madagascar: A Cluster-Randomized Trial

University of California Santa Cruz1 个研究点 分布在 1 个国家目标入组 3,080 人开始时间: 2024年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
3,080
试验地点
1
主要终点
Learning - Academic Test Scores

研究概览

简要总结

A previous study in schools in rural Madagascar found that a bundle of hygiene-focused interventions substantially improved girls' learning outcomes. This study disentangles the effects of physical infrastructure (latrines, handwashing basins) from other intervention components (peer sensitization and free sanitary pad distribution) in a cluster-randomized trial across 140 secondary schools in the Amoron'i Mania region. The trial originally measured learning and psychosocial wellbeing outcomes and was prospectively registered with the AEA RCT Registry (AEARCTR-0014423). The study team is now also collecting secondary health biomarker outcomes (e.g., salivary cortisol and blood-based C-reactive protein) and is registering those health biomarker endpoints with ClinicalTrials.gov.

详细描述

140 secondary schools were randomly assigned to one of four arms: (1) control, (2) infrastructure only, (3) sensitization + free sanitary pads, or (4) the full combined package. Outcomes are assessed via girls' surveys, teacher/director surveys, and school-level surveys at baseline (Oct 2024), midline, and endline.

This registration draws on two overlapping analytic samples. The first is the full 140-school evaluation sample (35 schools/arm; approximately 3,080 girls, ~22/school), used for the cognitive/academic composite, self-reported psychosocial well-being (GAD-7, PHQ-9), and health outcomes that do not require biospecimen collection or laboratory processing - self-reported infectious disease symptoms, mid-upper-arm circumference (MUAC), and self-reported urinary tract infection. These are collected during the social-science endline survey (May-June 2026), concurrent with the parent trial's learning and psychosocial data collection. The second is a 80-school biomarker subsample (approximately 20 schools/arm; ~1,360 girls, ~17/school), used specifically for salivary cortisol and blood-based C-reactive protein (CRP) drawn from a venipuncture. These outcomes require biospecimen collection, cold-chain transport, and laboratory assay, and are therefore restricted to the subset of schools logistically accessible for that purpose. They are collected at a separate endline health/biomarker visit at a Basic Health Center (July-August 2026, ~19 months post-baseline).

This registration covers the biomarker outcomes component of the trial, with data collection and analysis completing by approximately December 2026; the broader parent Kilonga 2 trial (registered with the AEA RCT Registry, AEARCTR-0014423) has a longer overall completion date of December 2027, covering the full set of learning and psychosocial endpoints. The biospecimen collection protocol includes additional biomarkers, cortisol and C-reactive protein, as registered secondary outcomes.

This trial was registered with ClinicalTrials.gov retrospectively, after participant enrollment had already begun. At inception (October 2024), the study was designed and IRB-approved (Paris School of Economics IRB #2024-046, approved September 17, 2024) as a social science evaluation focused on learning outcomes, and was prospectively registered with the AEA RCT Registry (AEARCTR-0014423) on September 23, 2024. Registration with ClinicalTrials.gov was initiated upon expanding the study to include health-related biomarker secondary endpoints, in order to comply with ICMJE requirements for biomedical journal publication. The Pre-Analysis Plan covering these health endpoints will be timestamped on the Open Science Framework prior to the start of health data collection in July 2026.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Investigator)

盲法说明

The outcome assessment team is separate from the implementation team, however due to the nature of the interventions there may be intervention contents visible during the assessment. Data analysis will be masked to randomization status of clusters.

入排标准

年龄范围
11 Years 至 21 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Girl identified in the Kilonga 2 evaluation sample (randomly selected during the December 2024-January 2025 baseline from class registers across the 140 participating schools); participants were 11-20 years old at baseline enrollment and are approximately 12-21 years old at the time of endline/health-outcomes data collection (May-August 2026)
  • Full evaluation sample (n~3,080; ~22 girls/school): all girls in the Kilonga 2 sample across the 140 schools are eligible for the cognitive, self-reported psychosocial, and non-biospecimen health outcomes, collected at the social-science endline.
  • Biomarker subsample (n~1,360; ~17 girls/school): girls attending one of the 80 schools selected for the health biomarker subsample (logistically accessible for biospecimen collection and cold-chain maintenance) are additionally eligible for salivary cortisol and blood-based C-reactive protein outcomes.
  • Informed consent obtained from parent/legal guardian, and assent obtained from the participant herself

排除标准

  • Adolescents not meeting the inclusion criteria above
  • Adolescents (or their parent/legal guardian) who refuse to participate or who withdraw consent/assent at any time
  • Adolescents for whom sample collection is judged impossible or contraindicated at the time of collection (e.g., health status precluding collection)

研究组 & 干预措施

Control

No Intervention

No intervention

School infrastructure only

Experimental

Construction of latrines and handwashing basins

干预措施: School infrastructure (Other)

Peer leadership/sensitization + sanitary pads

Experimental

Young Girl Leaders program, teacher sensitization, WASH competition, free sanitary pad vouchers

干预措施: Peer leadership/sensitization + sanitary pads (Behavioral)

Full package

Experimental

Combination of all interventions: Construction of latrines and handwashing basins and Peer leadership/sensitization + sanitary pads

干预措施: Peer leadership/sensitization + sanitary pads (Behavioral)

Full package

Experimental

Combination of all interventions: Construction of latrines and handwashing basins and Peer leadership/sensitization + sanitary pads

干预措施: School infrastructure (Other)

结局指标

主要结局

Learning - Academic Test Scores

时间窗: Up to 19 months

Standardized math/literacy test scores and official school grades (140-school full evaluation sample and 80-school biomarker subsample)

Learning - School Grades

时间窗: Up to 19 months

Official school grades (140-school full evaluation sample and and 80-school biomarker subsample)

Psychosocial Wellbeing - Heart Rate

时间窗: Up to 19 months

Objective stress measure: heart rate, beats per minute (140-school full evaluation sample and 80-school biomarker subsample)

Psychosocial Wellbeing - Blood Pressure

时间窗: Up to 19 months

Objective stress measure: systolic/diastolic blood pressure, mmHg (140-school full evaluation sample and 80-school biomarker subsample)

Psychosocial Wellbeing - Salivary Cortisol Reactivity

时间窗: Up to 19 months

Salivary cortisol reactivity (80-school biomarker subsample). Cortisol reactivity, calculated as the area under the curve with respect to increase (AUCi), based on samples collected at clinic arrival (baseline), 5-8 minutes pre-venipuncture, and 20 minutes post-venipuncture. AUCi is calculated using the trapezoidal method: the area under the curve with respect to ground (AUCg) is first calculated by summing the areas of the trapezoids formed between each pair of consecutive cortisol values and their corresponding time interval, then subtracting the area under the baseline value across the total sampling duration. This is expressed as AUCg = Σ\[(Ci + Ci+1)/2 × Ti\], where Ci is the cortisol concentration at a given timepoint, Ci+1 is the concentration at the subsequent timepoint, and Ti is the time interval between them. AUCi = AUCg - (baseline cortisol × total sampling duration). Reported in µg/dL×min.

Menstrual stigma

时间窗: Up to 17 months

Self-reported menstrual stigma (140-school full evaluation sample)

次要结局

  • Menstrual Knowledge(Up to 17 months)
  • Menstrual Behavior(Up to 17 months)
  • Student/Teacher Motivation(Up to 17 months)
  • Network Integration(Up to 17 months)
  • Bullying(Up to 17 months)
  • Self-reported Psychosocial Wellbeing(Up to 19 months)
  • Information Diffusion(Up to 17 months)
  • School Attendance(Up to 17 months)
  • Sexual Activity(Up to 17 months)
  • School History(Up to 17 months)
  • Pregnancy(Up to 19 months)
  • Hygiene Knowledge(Up to 17 months)
  • Hygiene Behavior(Up to 17 months)
  • Health - Infectious Disease Symptoms(Up to 19 months)
  • Health - Mid-Upper-Arm Circumference (MUAC)(Up to 19 months)
  • Health - Urinary Tract Infection(Up to 19 months)
  • Health - C-Reactive Protein(Up to 19 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验